医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
18期
167-167
,共1页
黄原%周卫东%潘明亮%张林
黃原%週衛東%潘明亮%張林
황원%주위동%반명량%장림
输血管理%疗效评价%量化分析
輸血管理%療效評價%量化分析
수혈관리%료효평개%양화분석
Blood transfusion management%Evaluation of curative ef ect%Quantitative analysis
目的以可量化实验室指标评价分析各临床科室用血的合理性、科学性、有效性,同时为输血管理委员会督查提供评价依据。方法即时监测患者输血前后相关指征变化和回顾性查阅分析输血病历,评价输血效果,分析输血合理性,并比较采取量化分析评价管理前后的临床合理用血效果。结果2011年926例输血病例中无效输注210例(22.7%);执行输血疗效评价后2012年同期相比1028例输血病例中无效输注156例(15.2%),χ2=18.02,P<0.01。结论通过操作性强的输血疗效评价机制能更客观指导临床科室科学合理用血,提高输血管理委员会监管及时性。
目的以可量化實驗室指標評價分析各臨床科室用血的閤理性、科學性、有效性,同時為輸血管理委員會督查提供評價依據。方法即時鑑測患者輸血前後相關指徵變化和迴顧性查閱分析輸血病歷,評價輸血效果,分析輸血閤理性,併比較採取量化分析評價管理前後的臨床閤理用血效果。結果2011年926例輸血病例中無效輸註210例(22.7%);執行輸血療效評價後2012年同期相比1028例輸血病例中無效輸註156例(15.2%),χ2=18.02,P<0.01。結論通過操作性彊的輸血療效評價機製能更客觀指導臨床科室科學閤理用血,提高輸血管理委員會鑑管及時性。
목적이가양화실험실지표평개분석각림상과실용혈적합이성、과학성、유효성,동시위수혈관리위원회독사제공평개의거。방법즉시감측환자수혈전후상관지정변화화회고성사열분석수혈병력,평개수혈효과,분석수혈합이성,병비교채취양화분석평개관리전후적림상합리용혈효과。결과2011년926례수혈병례중무효수주210례(22.7%);집행수혈료효평개후2012년동기상비1028례수혈병례중무효수주156례(15.2%),χ2=18.02,P<0.01。결론통과조작성강적수혈료효평개궤제능경객관지도림상과실과학합리용혈,제고수혈관리위원회감관급시성。
Objective to evaluate and analyses the rationality, scientific, validity of the blood transfusion in al the clinical department with quantifiable lab indicators, as wel as to provide evaluation basis for the supervision by management commit ee of blood transfusion. Methods by monitoring the indications changes of patients before and after blood transfusion and reviewing retrospectively transfusion records, evaluating transfusion ef ect, and comparative evaluation of quantitative analysis for management to take before and after the ef ect of the appropriate clinical use of blood. Results 210 cases of invalid transfusion (22.7%) in 926 cases of blood transfusion in 2011;156cases of invalid transfusion (15.2%) in 1028 cases after performing the evaluation of blood transfusion ef ect in the same period of 2012. X2=18.02, P<0.01. Conclusion guide the clinical department to conduct blood transfusion more rational y and scientifical y through the evaluation mechanism of blood transfusion ef ect with high operationality, so as to improve the regulation timeliness of blood transfusion management commit ee.